Results 111 - 120 of 501 : Previous 8 9 10 11 12 13 14 15 16 Next
Ignore Pfizer's Financials for Now
It's the pipeline that matters.
Here's How Teva Pharmaceutical Industries May Be Failing You
Keep your eye on margins.
Pfizer: Dividend Dynamo or Blowup?
Let's take a look at the numbers.
A decent-looking quarter, but a turnaround could still take awhile.
Protect against a higher cost of living.
2011's Top Dividend Aristocrats
Have a look at these dividend stalwarts.
Let's take a look.
The Motley Fool's Weekly Editors' Picks
Three of the week's most educating, amusing, and enriching articles.
Stock's on a tear, but where is it headed?
The Extraordinary Power of Dividends: Abbott Laboratories Edition
Focusing on what counts.
Results 111 - 120 of 501 : Previous 8 9 10 11 12 13 14 15 16 Next